Cabozantinib for Carcinoid and Pancreatic NETs: ' Encouraging ' Cabozantinib for Carcinoid and Pancreatic NETs: ' Encouraging '

A phase 2 trial demonstrated that cabozantinib has promise in the treatment of advanced carcinoid and pancreatic neuroendocrine tumors.Medscape Medical News

Source: Medscape Medical News Headlines - January 25, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news